logo

For the Inventor, By the Inventor

Scotch Plains, NJ, United States of America

Joanne Waldstreicher

USPTO Granted Patents = 20

Average Co-Inventor Count = 2.1

ph-index = 8

Forward Citations = 337(Granted Patents)


Company Filing History:

goldMedal19 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal1 out of 832,891 
Other
 patents

Years Active: 1996-2003

Loading Chart...
20 patents (USPTO):Explore Patents
1. 6525073 - Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist (2003-02-25),
2. 6486204 - Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug (2002-11-26),
3. 6403640 - Method for treating chronic prostatitis or chronic pelvic pain syndrome (2002-06-11),
4. 6355649 - Method of treating seborrhea with 5-&agr; reductase inhibitors (2002-03-12),
5. 6352997 - Method of improving in-vitro fertilization (2002-03-05),
6. 6329401 - Enhancement of sleep with a tachykinin antagonist (2001-12-11),
7. 6268377 - Method for treating androgen-related conditions (2001-07-31),
8. 6174892 - Method of treating acne with 5-&agr; reductase inhibitors (2001-01-16),
9. 6054455 - Method for treating or preventing chronic nonbacterial prostatitis and (2000-04-25),
10. 5981543 - Method of treating androgenic alopecia with 5.alpha.-reductase inhibitors (1999-11-09),
11. 5945412 - Methods and compositions for preventing and treating bone loss (1999-08-31),
12. 5942519 - Prevention of precipitated acute urinary retention (1999-08-24),
13. 5935968 - Methods for treating polycystic ovary syndrome (1999-08-10),
14. 5872126 - Methods and compositions for treating preterm labor (1999-02-16),
15. 5824686 - Method of treating androgenic alopecia with 5-alpha reductase inhibitors (1998-10-20),

Title: The Innovative Contributions of Joanne Waldstreicher

Introduction

Joanne Waldstreicher, a prominent inventor based in Scotch Plains, NJ, has made significant strides in the field of medical research and innovation. With an impressive portfolio of 20 patents, she has contributed to advancements in treatments for various health conditions. Her work exemplifies the intersection of science and innovation, impacting countless lives through her inventions.

Latest Patents

Among her most recent patents, Joanne has focused on two critical areas of healthcare. The first patent addresses the prevention or treatment of insomnia using a neurokinin-1 receptor antagonist. This innovative solution targets the alteration of circadian rhythmicity, thereby alleviating circadian rhythm disorders and enhancing the overall quality of sleep. The second patent involves the treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug. This groundbreaking approach presents a compound useful in treating or preventing prostate cancer, improving the efficacy of treatment when used alone or in combination with other medications.

Career Highlights

Throughout her career, Joanne has held pivotal roles in renowned companies, including Merck & Company, Inc. Her expertise and contributions have positioned her as a leader in her field, driving forward innovative solutions for critical healthcare challenges. Her dedication to research and development highlights her commitment to fostering advancements that benefit patients and the medical community.

Collaborations

Joanne's journey in innovation has been enriched through collaborations with notable coworkers such as Keith D Kaufman and Elizabeth Stoner. Working alongside these talented individuals, she has further expanded her knowledge and contributed to the creation of impactful solutions that address pressing health concerns.

Conclusion

Joanne Waldstreicher's contributions to the field of medical innovation are both profound and noteworthy. Her latest patents reflect her commitment to improving patient outcomes and enhancing healthcare solutions. As an accomplished inventor, she continues to inspire future generations of researchers and inventors in their pursuit of groundbreaking advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…